UY28828A1 - Nueva forma cristalina de ácido 8-ciano-1-ciclopropil-7-(1s, 6s-2,8-diazabiciclo(4.3.0)nonan-8-il)-6-fluoro-1,4-dihidro-4-oxo-3-quinolincarboxílico - Google Patents

Nueva forma cristalina de ácido 8-ciano-1-ciclopropil-7-(1s, 6s-2,8-diazabiciclo(4.3.0)nonan-8-il)-6-fluoro-1,4-dihidro-4-oxo-3-quinolincarboxílico

Info

Publication number
UY28828A1
UY28828A1 UY28828A UY28828A UY28828A1 UY 28828 A1 UY28828 A1 UY 28828A1 UY 28828 A UY28828 A UY 28828A UY 28828 A UY28828 A UY 28828A UY 28828 A1 UY28828 A1 UY 28828A1
Authority
UY
Uruguay
Prior art keywords
chinolincarboxyl
ciclopropil
diazabiciclo
dihidro
ciano
Prior art date
Application number
UY28828A
Other languages
English (en)
Inventor
Dr Iris Heep
Dr Hubert Rast
Dr Alfons Grunenberg
Dr Werner Hallenbach
Dr Jordi Benet-Buchholz
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of UY28828A1 publication Critical patent/UY28828A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

La presente invención se refiere al trihidrato de pradofloxacino, a procedimientos para su preparación así como a agentes antivacterianos que contienen este.
UY28828A 2004-04-01 2005-03-30 Nueva forma cristalina de ácido 8-ciano-1-ciclopropil-7-(1s, 6s-2,8-diazabiciclo(4.3.0)nonan-8-il)-6-fluoro-1,4-dihidro-4-oxo-3-quinolincarboxílico UY28828A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004015981A DE102004015981A1 (de) 2004-04-01 2004-04-01 Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure

Publications (1)

Publication Number Publication Date
UY28828A1 true UY28828A1 (es) 2005-11-30

Family

ID=34962324

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28828A UY28828A1 (es) 2004-04-01 2005-03-30 Nueva forma cristalina de ácido 8-ciano-1-ciclopropil-7-(1s, 6s-2,8-diazabiciclo(4.3.0)nonan-8-il)-6-fluoro-1,4-dihidro-4-oxo-3-quinolincarboxílico

Country Status (32)

Country Link
US (1) US7977484B2 (es)
EP (1) EP1737859B1 (es)
JP (1) JP5190259B2 (es)
KR (1) KR101217678B1 (es)
CN (1) CN100591681C (es)
AR (2) AR048099A1 (es)
AT (1) ATE450536T1 (es)
AU (1) AU2005231918B2 (es)
BR (1) BRPI0509529B8 (es)
CA (1) CA2561635C (es)
CY (2) CY1109762T1 (es)
DE (3) DE102004015981A1 (es)
DK (1) DK1737859T3 (es)
ES (1) ES2335899T3 (es)
GT (1) GT200500043A (es)
HK (1) HK1104537A1 (es)
HR (1) HRP20100097T1 (es)
IL (1) IL178353A (es)
MY (1) MY140998A (es)
NO (1) NO337279B1 (es)
NZ (1) NZ550226A (es)
PE (1) PE20060170A1 (es)
PL (1) PL1737859T3 (es)
PT (1) PT1737859E (es)
RU (1) RU2383543C2 (es)
SI (1) SI1737859T1 (es)
SV (1) SV2006002070A (es)
TW (1) TWI350755B (es)
UA (1) UA84329C2 (es)
UY (1) UY28828A1 (es)
WO (1) WO2005097789A1 (es)
ZA (1) ZA200608072B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006010643A1 (de) 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
DE102007026550A1 (de) * 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
CA3053211A1 (en) 2017-02-13 2018-08-16 Bayer Animal Health Gmbh Liquid composition containing pradofloxacin and antioxidants
CN115710267A (zh) * 2022-11-30 2023-02-24 天津大学 一种普拉沙星水合物晶体及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323213B1 (en) * 1996-02-23 2001-11-27 Bayer Aktiengesellschaft Possibly substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives
DE19854356A1 (de) 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854357A1 (de) 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854355A1 (de) 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908449A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
DE19908448A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation D von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo[4.3.0)nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino incarbonsäure
US6627646B2 (en) * 2001-07-17 2003-09-30 Sepracor Inc. Norastemizole polymorphs

Also Published As

Publication number Publication date
TW200602053A (en) 2006-01-16
WO2005097789A1 (de) 2005-10-20
AU2005231918A1 (en) 2005-10-20
KR101217678B1 (ko) 2013-01-02
EP1737859B1 (de) 2009-12-02
CN1938304A (zh) 2007-03-28
KR20070014157A (ko) 2007-01-31
AU2005231918B2 (en) 2011-05-12
IL178353A (en) 2011-08-31
UA84329C2 (en) 2008-10-10
IL178353A0 (en) 2007-02-11
PE20060170A1 (es) 2006-04-13
JP5190259B2 (ja) 2013-04-24
SV2006002070A (es) 2006-03-15
EP1737859A1 (de) 2007-01-03
CA2561635C (en) 2012-10-16
NO20064988L (no) 2006-10-31
TWI350755B (en) 2011-10-21
DE502005008620D1 (de) 2010-01-14
BRPI0509529B8 (pt) 2021-05-25
JP2007530614A (ja) 2007-11-01
NZ550226A (en) 2009-11-27
PL1737859T3 (pl) 2010-04-30
AR048099A1 (es) 2006-03-29
SI1737859T1 (sl) 2010-03-31
BRPI0509529B1 (pt) 2019-05-21
CY1109762T1 (el) 2014-09-10
DE122011100055I1 (de) 2012-03-15
DE102004015981A1 (de) 2005-10-20
NO337279B1 (no) 2016-02-29
RU2383543C2 (ru) 2010-03-10
ZA200608072B (en) 2008-01-08
RU2006138362A (ru) 2008-05-10
CN100591681C (zh) 2010-02-24
ES2335899T3 (es) 2010-04-06
CA2561635A1 (en) 2005-10-20
AR105177A2 (es) 2017-09-13
CY2011018I1 (el) 2016-12-14
PT1737859E (pt) 2010-02-03
HRP20100097T1 (hr) 2010-04-30
ATE450536T1 (de) 2009-12-15
HK1104537A1 (en) 2008-01-18
US20080125458A1 (en) 2008-05-29
GT200500043A (es) 2006-02-17
US7977484B2 (en) 2011-07-12
BRPI0509529A (pt) 2007-09-18
MY140998A (en) 2010-02-12
DK1737859T3 (da) 2010-04-06

Similar Documents

Publication Publication Date Title
DK1881967T3 (da) Substituerede benzo (D) isoaxol-3-yl-amin-forbindelser som analgetika
NO20080129L (no) Fremgangsmate for fremstilling av dihydrokinazoliner
BRPI0520870B8 (pt) compostos intermediários para a preparação de alfa-mercaptoacetanilidas de s-triazolila
BRPI0512683A (pt) compostos anti-virais
NO20076371L (no) Fremgangsmate for fremstilling av fenoliske 4-bifenylylazetidin-2-oner
CR20120283A (es) Inhibidor de bromodominio de benzodiazepina
CR10157A (es) Compuestos químicos
EA201170772A1 (ru) Органические соединения
ECSP11011181A (es) Compuestos orgánicos
BRPI0507312A (pt) derivados de quinolina para uso como inibidores micobacterianos
MX2007003108A (es) Compuestos imidazo-3-il-amina sustituidos y biciclicos.
ES2338590T3 (es) Procedimiento regioselectivo de preparacion de benzoimidazoltiofenos.
DOP2006000017A (es) Pirazolopiridinas y sales de las mismas, una composición farmaceútica que comprende dichos compuestos, un método para prepararlos y su uso
CY1106902T1 (el) Κρυσταλλικη μορφη μηλεϊνικης ασεναπινης
AR057148A1 (es) Combinaciones farmacologicas para el tratamiento de enfermedades de las vias respiratorias
UY30451A1 (es) 18-metil-19-nor-androst-4-en-17,17-espiroéteres (18-metil-19-nor-20-espirox-4-en-3-onas),ase como preparaciones farmacéuticas que lo contienen.
ECSP099070A (es) Bencilaminas, un proceso para su producción y su uso como agentes anti-inflamatorios
TW200716564A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
AR058253A1 (es) Procedimiento para la preparacion de ferri-succinilcaseina
AR105177A2 (es) Forma cristalina de ácido 8-ciano-1-ciclopropil-7-(1s,6s-2,8-diazabiciclo-(4.3.0)nonan-8-il)-6-flúor-1,4-dihidro-4-oxo-3-quinolincarboxílico
MX2008011576A (es) Compuestos de imidazo[2,1-b]tiazol sustituidos y su uso para la produccion de farmacos.
MX2009004991A (es) Derivados de monoacetato de ciclopenteno-diol.
UY32744A (es) Derivados de 2-carboxamida-7-piperazinil-benzofurano 774
TW200613317A (en) Steroid prodrugs with androgenic action
MX2010006636A (es) Uso de derivados de acido tetramico para controlar nematodos.

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20170220